Third, although HER2‐low breast cancer was a biologically heterogeneous group, we did not further stratify the population based on hormone receptor (HR) status (e.g., HR‐positive vs. triple‐negative) due to the limited sample size. The gene discussed is ERBB2; the disease is breast carcinoma.